Citations Report

Clinical Practice : Citations & Metrics Report

Articles published in Clinical Practice have been cited by esteemed scholars and scientists all around the world.

Clinical Practice has got h-index 29, which means every article in Clinical Practice has got 29 average citations.

Following are the list of articles that have cited the articles published in Clinical Practice.

  2021 2020 2019 2018 2017 2016

Year wise published articles

50 27 55 66 38 13

Year wise citations received

494 462 352 277 260 226
Journal total citations count 3847
Journal impact factor 12.24
Journal 5 years impact factor 8.50
Journal cite score 10.62
Journal h-index 29
Journal h-index since 2018 21
Journal Impact Factor 2020 formula
IF= Citations(y)/{Publications(y-1)+ Publications(y-2)} Y= Year
Journal 5-year Impact Factor 2020 formula
Citations(2016 + 2017 + 2018 + 2019 + 2020)/
{Published articles(2016 + 2017 + 2018 + 2019 + 2020)}
Journal citescore
Citescorey = Citationsy + Citationsy-1 + Citationsy-2 + Citations y-3 / Published articlesy + Published articlesy-1 + Published articlesy-2 + Published articles y-3
  • Mihalyi A, Simsa P, Mutinda KC, Meuleman C, Mwenda JM, et al. (2006) Emerging drugs in endometriosis. Expert opinion on emerging drugs. 11: 503-524.
    View at Publisher | View at Google Scholar
  • Simsa P, Mihalyi A, Schoeters G, Koppen G, Kyama CM, Den Hond EM, Fülöp V, D’Hooghe TM. Increased exposure to dioxin-like compounds is associated with endometriosis in a case–control study in women. Reproductive biomedicine online. 20(5):681-688.

    View at Publisher | View at Google Scholar
  • Heard ME, Simmons CD, Simmen FA, Simmen RC (2014) Krüppel-like factor 9 deficiency in uterine endometrial cells promotes ectopic lesion establishment associated with activated notch and hedgehog signaling in a mouse model of endometriosis. Endocrinology. 155:1532-1546.

    View at Publisher | View at Google Scholar
  • Vodolazkaia A, Bossuyt X, Fassbender A, Kyama CM, Meuleman C, et al. (2011) A high sensitivity assay is more accurate than a classical assay for the measurement of plasma CRP levels in endometriosis. Reproductive Biology and Endocrinology. 9:113.

     

    View at Publisher | View at Google Scholar
  • Kyama CM, Overbergh L, Mihalyi A, Cuneo S, Chai D, et al. (2008) Effect of recombinant human TNF–binding protein-1 and GnRH antagonist on mRNA expression of inflammatory cytokines and adhesion and growth factors in endometrium and endometriosis tissues in baboons. Fertility and sterility. 89(5):1306-13.
    View at Publisher | View at Google Scholar
  • AvcioÄŸlu SN, Altinkaya SÖ, Küçük M, Demircan-Sezer S, Yüksel H (2014) Can platelet indices be new biomarkers for severe endometriosis?. ISRN obstetrics and gynecology. 2014.
    View at Publisher | View at Google Scholar
  • Kyama CM, Mihalyi A, Chai D, Simsa P, Mwenda JM, et al. (2007) Baboon model for the study of endometriosis. Women’s Health. 3:637-646.
    View at Publisher | View at Google Scholar
  • Simsa P, Mihalyi A, Kyama CM, Mwenda JM, Fülöp V, et al. (2007) Future of endometriosis research. Women’s Health. 3: 647-654.
    View at Publisher | View at Google Scholar
  • Bodur S, Gün Ä°, Babayigit MA (2013) The significance of mean platelet volume on diagnosis and management of adenomyosis. Medicinski Glasnik. 10(1).

     

    View at Publisher | View at Google Scholar
  • Mardanian F, Sheikh-Soleimani Z (2014) The diagnostic role of cervico-vaginal fluid interleukins-1α in endometriosis: A case-control study. Journal of research in medical sciences: the official journal of Isfahan University of Medical Sciences. 19:1145.
    View at Publisher | View at Google Scholar
  • Xiong W, Wang P (2012) Clinical Significance of Determination of Serum hs-CRP, CA-125 and CA-199 in Patients with Ovarian Endometriosis before and after B-mediated Ultrasound. International Journal of Laboratory Medicine 33: 1493- 1495.

    View at Publisher | View at Google Scholar
  • Yagmur E, Bastu ER, Karamustafaoglu-Balci B, Akhan SE, Buyru F (2013) Non-invasive diagnosis of endometriosis based on a combined analysis of four plasma biomarkers. Centr Eur J Immunol. 38:154-158.
    View at Publisher | View at Google Scholar
  • Bodur S, Dundar O, Pektas MK, Babayigit MA, Ozden O, et al. (2015) The clinical significance of classical and new emerging determinants of adenomyosis. International journal of clinical and experimental medicine. 8:7958.
    View at Publisher | View at Google Scholar
  • Sheaves C (2013) Advances in endometriosis treatment. The Nurse Practitioner. 38:42-47.
    View at Publisher | View at Google Scholar
  • Bodur S, Gün Ä°, Babayigit MA (2012) The significance of mean platelet volume on diagnosis and man-agement of adenomyosis. Med Glas.
    View at Publisher | View at Google Scholar
  • Abou-Gamrah A, Ashoush S, Elsabaa H, Abdelnaby R (2015) Potential of the Blood Neutrophil to Lymphocyte Ratio, the Serum Interleukin-6, and the Fibroblast Growth Factor-2 in the Diagnosis of Endometriosis. Int. J. Curr. Microbiol. App. Sci. 4:441-450.
    View at Publisher | View at Google Scholar
  • Mihalyi A, Simsa P, Mutinda KC, Meuleman C. E) _rp_ert. Expert Opin. Emerging Drugs. 2006;31503624:31503624.
    View at Publisher | View at Google Scholar
  • Kyama CM. A high sensitivity assay is more accurate than a classical assay for the measurement of plasma CRP levels in endometriosis.
    View at Publisher | View at Google Scholar
  • Simsa P, Járási ZÉ, Fülöp V (2007) Environmental dioxin compounds as the cause of endometriosis and other diseases. Orvosi hetilap. 148:1745-1750.
    View at Publisher | View at Google Scholar
  • Dungo RT and Keating GM, 2013. Afatinib: first global approval. Drugs, 73(13), pp.1503-1515.

    View at Publisher | View at Google Scholar
  • Keating GM, 2014. Afatinib: a review of its use in the treatment of advanced non-small cell lung cancer. Drugs, 74(2), pp.207-221.

    View at Publisher | View at Google Scholar
  • Khelwatty SA, Essapen S, Seddon AM and Modjtahedi H, 2011. Growth response of human colorectal tumour cell lines to treatment with afatinib (BIBW2992), an irreversible erbB family blocker, and its association with expression of HER family members. International journal of oncology, 39(2), p.483.

    View at Publisher | View at Google Scholar
  • Shen W, Zhang A, Maung J and Zheng X, 2015. Alkyne substituted quinazoline compound and methods of use. U.S. Patent 9,090,588.

    View at Publisher | View at Google Scholar
  • Shen W, Xiao W, Maung J, Zhang A, Zheng X, et al. 2015. Quinazoline-7-ether compounds and methods of use. U.S. Patent 9,187,459.

    View at Publisher | View at Google Scholar
  • Santos ES, 2011. New discoveries in lung cancer biology: paving the road of personalized medicine. Therapy, 8(1), pp.1-4.

    View at Publisher | View at Google Scholar
  • Peled N, Roisman LC, Miron B, Pfeffer R, Lanman RB, et al. 2017. Sub-Clonal Therapy by two EGFR TKIs Guided by Sequential Plasma Cell-free DNA in EGFR-mutated Lung Cancer. Journal of Thoracic Oncology.

    View at Publisher | View at Google Scholar
  • Zhang Q and Wu YL, 2016. Safety and efficacy of targeted agents monotherapy in advanced NSCLC. Expert review of clinical pharmacology, 9(1), pp.143-155.

    View at Publisher | View at Google Scholar
  • De Boeck K, Zolin A, Cuppens H, Olesen HV and Viviani L, 2014. The relative frequency of CFTR mutation classes in European patients with cystic fibrosis. Journal of Cystic Fibrosis, 13(4), pp.403-409.

    View at Publisher | View at Google Scholar
  • Elborn JS, 2011. Treating cystic fibrosis infection, inflammation and ion channels. Therapy, 8(6), pp.583-585.

    View at Publisher | View at Google Scholar
  • Santos ES, 2011. New discoveries in lung cancer biology: paving the road of personalized medicine. Therapy, 8(1), pp.1-4.

    View at Publisher | View at Google Scholar
  • Overbye KM, Barrett JF (2005) Antibiotics: where did we go wrong?. Drug discovery today 10: 45-52.

    View at Publisher | View at Google Scholar
  • Barrett JF (2005) Can biotech deliver new antibiotics?. Current opinion in microbiology 8: 498-503.

    View at Publisher | View at Google Scholar
  • Dutta NK, Annadurai S, Mazumdar K, Dastidar SG, Kristiansen JE, et al. (2007) Potential management of resistant microbial infections with a novel non-antibiotic: the anti-inflammatory drug diclofenac sodium. International journal of antimicrobial agents 30:242-49.

    View at Publisher | View at Google Scholar
  • Mazumdar K, Dutta NK, Dastidar SG, Motohashi N, Shirataki Y (2006) Diclofenac in the management of E. coli urinary tract infections. in vivo 20: 613-19.

    View at Publisher | View at Google Scholar
  • Mazumdar K, Dastidar SG, Park JH, Dutta NK (2009) The anti-inflammatory non-antibiotic helper compound diclofenac: an antibacterial drug target. European journal of clinical microbiology & infectious diseases 28: 881.

    View at Publisher | View at Google Scholar
  • Mazumdar K, Kumar KA, Dutta NK (2010) Potential role of the cardiovascular non-antibiotic (helper compound) amlodipine in the treatment of microbial infections: scope and hope for the future. International journal of antimicrobial agents 36: 295-302.

    View at Publisher | View at Google Scholar
  • Fuad MM, Ferdowsy H, Hossain MN, Foysal MJ, Rahman MM (2012)  In-vitro antibacterial activity of common antibiotics and herb extracts to clinical isolates of Escherichia coli collected from UTI patient. International Journal of Research in Pharmaceutical and Biomedical Sciences 3: 987-92.

    View at Publisher | View at Google Scholar
  • Gulbrandsen HS. Synthesis of C-Ring Functionalized Phenanthridines employing Intramolecular Diels-Alder of Furan (IMDAF) as the Key Step (Master's thesis).

    View at Publisher | View at Google Scholar
  • Gupta AK, Singh S. JOURNAL OF SCIENTIFIC & INNOVATIVE RESEARCH.

    View at Publisher | View at Google Scholar
  • Yú J, GÇ” H, Yuán Y, Yú F, Chén X, et al. (2013) Diagnostic value of serum hs-CRP and CA125 in patients with endometriosis. Journal of Practical Laboratory Medicine. 2:84-87.

    View at Publisher | View at Google Scholar
  • Qíngānqún, GÇ”cuì Y, Dài YF (2014) Clinical significance of serum high-sensitivity C-reactive protein and adiponectin in patients with endometriosis. Chinese Journal of Postgraduates of Medicine. 16 (004): 533-534 View at Publisher | View at Google Scholar
  • Schiff MH, Burmester GR, Kent JD, Pangan AL, Kupper H, et al.(2006) Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis. Annals of the rheumatic diseases 65: 889-94.

    View at Publisher | View at Google Scholar
  • Knight C, Mauskopf J, Ekelund M, Singh A, Yang S, et al. (2012) Cost-effectiveness of treatment with etanercept for psoriasis in Sweden. The European Journal of Health Economics 13: 145-56.

    View at Publisher | View at Google Scholar
  • AUSTRALIA II. IMPORTANT HIGH COST MEDICINES.

    View at Publisher | View at Google Scholar
  • Moretti R, Torre P, Antonello RM, Vilotti C, Pizzolato G. New treatment options for vascular dementia.
    View at Publisher | View at Google Scholar
  • Moretti R, Torre P, Antonello RM, Cattaruzza T, Pizzolato G (2005) Memantine: Its Role in Vascular Dementia. Drug Design Reviews-Online. 2:449-456.
    View at Publisher | View at Google Scholar
  • Tiss A, Lengsfeld H, Carrière F, Verger R (2009) Inhibition of human pancreatic lipase by tetrahydrolipstatin: further kinetic studies showing its reversibility. Journal of Molecular Catalysis B: Enzymatic 58: 41-7.

    View at Publisher | View at Google Scholar
  • Ašler IL, Zehl M, Kovačić F, Müller R, Abramić M,et al. (2007) Mass spectrometric evidence of covalently-bound tetrahydrolipstatin at the catalytic serine of Streptomyces rimosus lipase. Biochimica et Biophysica Acta (BBA)-General Subjects 1770: 163-70.

    View at Publisher | View at Google Scholar
  • Tiss A, Lengsfeld H, Verger R (2010) A comparative kinetic study on human pancreatic and Thermomyces lanuginosa lipases: inhibitory effects of tetrahydrolipstatin in the presence of lipid substrates. Journal of Molecular Catalysis B: Enzymatic 62: 19-26.

    View at Publisher | View at Google Scholar
  • Turgay A (2009) Psychopharmacological treatment of oppositional defiant disorder. CNS drugs. 23:1-7.
    View at Publisher | View at Google Scholar

Relevant Topics

Awards Nomination

Select your language of interest to view the total content in your interested language

Journal Metrics:

Impact Factor: 12.24
Journal Citescore: 10.62
h-index: 29
PubMed NLM ID:  101579384
Journal Acceptance Rate: 40%
Article processing time : 30-45 Days

Google Scholar citation report
Citations : 3847

Clinical Practice received 3847 citations as per Google Scholar report


Clinical Practice peer review process verified at publons

Indexed In

flyer
flyer